|
Denise Pollard-Knight, PhD, is Managing Director of Nomura Phase4 Ventures, an affiliate of Nomura International plc. From January 1999 to March 2004, Dr. Pollard-Knight served as head of Healthcare Private Equity at Nomura International plc, a leading Japanese financial institution. Prior to joining Nomura, Dr. Pollard-Knight was a member of Rothschild Asset Management Ltd., an investment management firm, from January 1997 to January 1999. Dr. Pollard-Knight held several research and development management positions at Amersham-Pharmacia and Fisons plc. Dr. Pollard-Knight holds a PhD and BSc (Hons) from the University of Birmingham in England. Dr. Pollard-Knight completed post doctorate work as a Fulbright Scholar at the University of California, Berkeley. Dr Pollard-Knight currently serves on the Boards of Idenix Pharmaceuticals, ViaCell Inc, Nabriva Therapeutics and Develogen AG. She is currently a Trustee and a Council Member of the British Heart Foundation serving on the Executive Committee. | 